Clinical Trial Update: Long-term Oncologic Outcome of Breast-conserving Surgery in Breast Cancer Patients With BRCA1/2 Mutations

View source ↗

Summary

This clinical-trial update reports long-term oncologic outcomes for breast-conserving surgery in breast cancer patients with BRCA1/2 mutations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Hanyang University Seoul Hospital | Conditions: BRCA1/2 Mutation, Breast-conserving Surgery | Status: COMPLETED